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Bethesda, Maryland; and Chicago, IllinoisOBJECTIVES The aim of this study was to prospectively investigate the prevalence of fat deposition
in idiopathic dilated cardiomyopathy (DCM) by fat-water separation imaging. An auxiliary aim was to
determine the relationship between left ventricular (LV) fat deposition and characteristic myocardial
ﬁbrosis, as well as cardiac functional parameters.
BACKGROUND Idiopathic DCM remains the most common cause of heart failure in young people
referred for cardiac transplantation; little is known about the clinical value of fat deposition in DCM.
METHODS A total of 124 patients with DCM were studied after written informed consent was ob-
tained. The magnetic resonance imaging scan protocols included a series of short-axis LV cine imaging
for functional analysis, fat-water separation imaging, and late gadolinium enhancement (LGE) imaging.
Fat deposition and ﬁbrosis location were compared to the scar regions on LGE images using a 17-
segment model. Statistical comparisons of LV global functional parameters, ﬁbrosis volumes, and fat
deposition were carried out using the Pearson correlation, Student t test, and multiple regressions.
RESULTS The patients had a 41.9% (52 of 124) prevalence of positive LGE, and 12.9% (16 of 124) fat
deposition prevalence was found in this DCM cohort. The patients with fat deposition had larger LV end-
diastolic volume (LVEDV) index (140.8  20.2 ml/m2 vs. 123.4  15.8 ml/m2; p < 0.01), larger LV end-
systolic volume (LVESV) index (111.3  19.2 ml/m2 vs. 87.0  20.3 ml/m2; p < 0.01), and decreased
LV ejection fraction (LVEF) (21.1  7.1% vs. 30.0  10.7%; p < 0.01). Higher volumes of LGE were found
in the group with myocardial fat deposition (18.39  9.0 ml vs. 13.40  6.54 ml; p ¼ 0.001), as well as a
higher percentage of LGE/LV mass (19.11  7.78% vs. 13.60  4.58%; p ¼ 0.000). The volume of fat depo-
sition was correlated with scar volume, LVEF, LVEDV index, and LVESV index.
CONCLUSIONS Fat deposition is a common phenomenon in DCM, and it is associated with DCM
characteristics such as ﬁbrosis volume and LV function. (J Am Coll Cardiol Img 2013;6:889–98)
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CO = cardiac output
DCM = dilated cardiomyop
LGE = late gadolinium
enhancement
LV = left ventricle/ventricu
LVEDV = left ventricular
end-diastolic volume
LVEF = left ventricular
ejection fraction
LVESV = left ventricular
end-systolic volume
LVM = left ventricular mas
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890diopathic dilated cardiomyopathy (DCM) is a
syndrome characterized by cardiac enlargement
and global systolic dysfunction in the presence of
normal arteries (1,2) that remains an important
cause of systolic heart failure and the most common
cause of heart failure in young people referred for
cardiac transplantation (3). Histological character-
istics include substantial hypertrophy and degener-
ation of myocytes, varying degrees of interstitial
ﬁbrosis, and occasional small clusters of lympho-
cytes and ﬁbrofatty inﬁltration (4).
Many researchers have studied the clinical value of
late gadolinium enhancement (LGE) in patients with
DCM, and it was believed that LGEwas an important
prognostic indicator of DCM (5,6). However, it was
impossible to separate ﬁbrosis tissue from fat in con-
ventional LGE images because both fat and ﬁbrosis
manifested as high signals.Until now, little researchhas
focused on fat deposition in patients with DCM (7,8).for Cardiovas
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intense in fat saturation fast spin-echo or
short tau inversion recovery images. The
ﬁrst water-fat separation method was
described by Reeder et al. (9) using steady-
state free precession with the iterative
decomposition of water and fat with echo
asymmetry and least-squares estimation
(IDEAL) technique.There have beenmany
publications from this group regarding the
IDEAL technique on fat detection (10–12).
However, there is little research speciﬁcally
focused onmyocardial fat detected with thistechnique. In this study, we used the fat-sensitive
magnetic resonance sequence fat-water separation
using VARiable PROjection (VARPRO) (13) to
investigate fat deposition in DCM. The aim of the
present study was to prospectively investigate the
prevalence of fat deposition in DCM by fat-water
separation imaging and to determine the
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METHODS
Patient population. This study was approved by the
institutional review board, and all patients gave
written consent prior to study initiation. A total of
140 consecutive patients (all of Asian race) with a
diagnosis of idiopathic DCM made within the pre-
ceding 2 weeks were enrolled in this study. Diagnosis
was established by clinical examination, echocardi-
ography, and normal coronary angiograms. The in-
clusion criterion was the presence of left ventricular
ejection fraction (LVEF) #45% at baseline echo-
cardiography or cardiac magnetic resonance (CMR)
imaging. Exclusion criteria included the diagnosis of
signiﬁcant coronary artery disease (deﬁned as the
presence of 50% luminal stenosis in an epicardial
coronary artery at angiography, noninvasive stress
imaging suggestive of ischemia, history of previous
coronary intervention, or prior myocardial infarc-
tion), severe valvular heart disease, thyroid dysfunc-
tion, inﬁltrative cardiomyopathy, extracardiac
systemic features suggesting sarcoidosis or amyloid-
osis, heavy alcohol use (>90 g of alcohol per day),
peripartum cardiomyopathies, chemotherapy-
induced cardiomyopathy, hypertrophic cardiomyop-
athy, and myocarditis. Myocarditis was excluded in
potential DCM cases by the absence of classic clinical
features, presence of normal serum troponin I con-
centration at presentation, and lack of evidence of
myocardial edema on T2-weighted CMR (14).
Exclusion from the CMR examination was
mandated by renal impairment (estimated glomerular
ﬁltration rate of 60 ml/min) or other conventional
CMR contraindications.
CMR imaging protocol. All CMR examinations were
performed with a 1.5-T scanner (Magneton Avanto,
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891with the patient in a supine position. Images were
acquired during suspended respiration at end-
inspiration with vector-electrocardiographic gating
and an 8-channel phased-array body receive coil. The
study consisted of: 1) LV cine functional imaging; 2)
LGE imaging; and 3) water-fat separation imaging
with VARPRO sequentially. For each part of the
study, identical section locations were used, consist-
ing of 8 parallel 6-mm–thick short-axis sections with
a 4- to 6-mm section gap spanning the LV myocar-
dium from the base to the apex of the heart. Three
long-axis views of the LV were acquired with iden-
tical imaging parameters. True fast imaging with
steady-state precession was used for cine imaging.
The following imaging parameters were used: repe-
tition time/echo time 3.0/1.1; ﬂip angle 85 to 65;
bandwidth 800Hz/pixel;matrix size 192 256; pixel
size 2.2  1.6 mm2; integrated parallel imaging
technique acceleration factor  2; and temporal res-
olution 38 to 45 ms/frame depending on the R-R
interval.
LGE imagingwas performedwith a pulse sequence
for T1-weighted imaging with phase-sensitive
inversion recovery. The gadodiamide (Magnevist,
Bayer HealthCare Pharmaceuticals, Wayne, New
Jersey) agent dose was 0.2 mmol/kg. Images were
collected 10 to 15 min after the contrast administra-
tion was performed with an automated injector
(Spectris, Medrad, Pittsburgh, Pennsylvania).
A multiecho gradient-recalled echo sequence was
implemented with fat-water separation using the
VARPRO multipoint Dixon reconstruction method
(15) with T2* correction (16). The imaging sequence
was vector-electrocardiogram triggered, with 2 R-R
intervals between inversions, and used an echo-train
readout with 4 echoes with ﬂyback gradients for
monopolar readout. The echo-train readout was used
to increase the acquisition efﬁciency and thereby
maintain acceptable breath-hold duration. Typical
parameters for imaging were bandwidth 930 Hz/
pixel; echo time 1.35, 3.10, 4.85, and 6.8 ms; repe-
tition time 374.25 ms; ﬂip angle 24; image matrix
192  112; views per segment 5; breath-hold dura-
tion 16 heart beats, including 2 initial heart beats
discarded for transition to steady state. Phase-
encoding oversampling was used in cases when the
matrix size was rounded up due to segmentation.
The inversion time was autoadjusted to minimize the
signal intensity of normal myocardium.
Image analysis. All images were analyzed ofﬂine
using a workstation with commercially available
software (Argus version 3.3, Siemens).
For all patients, the CMR scans were placed in
random order after the identity information wasremoved. The doctor who was blinded to the clin-
ical data evaluated the CMR images. Epicardial and
endocardial borders of contiguous short-axis slices
were manually traced. End-diastole and end-systole
were visually determined and allowed calculation of
left ventricular mass (LVM), left ventricular end-
diastole volume (LVEDV), and left ventricular
end-systole volume (LVESV), from which LVEF,
cardiac output (CO), and cardiac index were
derived. The LVM was calculated by subtracting
endocardial from epicardial volume at end-diastole
and multiplying by 1.05 g/cm3 (17). All of the
global functional parameters were indexed to body
surface area (18).
The extent of LGE was determined automatically
by computer counting of all hyperenhanced pixels in
the myocardium on each of the LGE images.
Hyperenhanced pixels resembling LGEwere deﬁned
as those with image intensities of 2 SD above the
mean of image intensities in a remote myocardial
region in the same image.
Fibrosis contours were drawn on the reconstructed
water-only images by using the same software.
Fibrosis was deﬁned as thosewith image intensities of
2 SD above the mean of image intensities in a remote
myocardial region in the water-only images.
A fat fraction (FF) map (Equation #1) was used
to determine the presence of fat (19) by using the
fat-only (F) and water-only (W) images. Before
processing the FF map, a magnitude discrimination
was performed to correct bias from T1 and noise
(20,21), and fat pixels were deﬁned as higher than
50% in the fraction map (Online Appendix).
Equation 1: FF ¼ F=W þ F 100%
The LGE, ﬁbrosis, and fat volumes and per-
centages of LVM were calculated. All image anal-
ysis was performed by a single investigator with 11
years of CMR image analysis experience. To assess
the reproducibility, LGE, fat, and ﬁbrosis volume
analyses were performed by 2 independent experi-
enced observers (with 11 years and 8 years of CMR
image analysis experience) for patients with fat
deposition.
Statistical analysis. Continuous variables are pre-
sented as the mean  SD. Interobserver variability
was assessed using the Bland and Altman method
(22). Comparisons between continuous variables in
the 3 groups of patients included in the study
were performed by 1-way analysis of variance. The
results were tested for normality with the poly-
nomial normality test. If the overall p value was
#0.05, Bonferroni multiple comparison was used as
Table 1. Demographics of Study Cohort
All Patients
(N [ 124)
Negative LGE
(n [ 72)
Fat Deposition Absent
(n [ 36)
Fat Deposition Present
(n [ 16) p Value
Age, yrs 51.0  16.3 46.7  17.7 57.7  11.0 55.1  13.6 0.002
No. of men 89 (71.8) 54 (75.0) 23 (63.9) 12 (75.0) 0.481
Body mass index, kg/m2 20.72  1.57 20.56  1.48 20.99  1.73 20.82  1.58 0.399
Body surface area, m2 1.78  0.19 1.77  0.19 1.79  0.16 1.82  0.20 0.628
Alcohol use* 49 (39.5) 27 (37.5) 15 (41.2) 7 (43.8) 0.710
NYHA functional class
II 33 (26.6) 23 (31.9) 9 (25.0) 1 (6.3)
III 57 (46.0) 32 (44.4) 16 (44.4) 9 (56.3) 0.018
IV 34 (27.4) 17 (23.6) 11 (30.6) 6 (37.5)
Medication
Beta-blocker 107 (86.3) 57 (79.2) 34 (94.4) 16 (100) 0.000
ACE inhibitor or ARB 102 (82.3) 56 (77.8) 30 (83.3) 15 (93.8) 0.047
Diuretics 101 (81.5) 51 (70.8) 31 (86.1) 15 (93.8) 0.011
Values are mean  SD or n (percentage calculated from raw data). *<90 g of alcohol per day.
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin receptor blocker; LGE ¼ late gadolinium enhancement; NYHA ¼ New York Heart Association.
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892a post-test. If the overall p value was >0.05, then
least signiﬁcant difference multiple comparison was
used as a post-test. Moreover, linear correlation was
used to evaluate the correlation index (Pearson co-
efﬁcient, r) between LVEF and fat, LVEF and
LGE, LVEF and ﬁbrosis, and LVEF and LVMFigure 1. Bland and Altman Analyses of LGE, Fibrosis, and Fat Volu
(A) Late gadolinium enhancement (LGE) volume. (B) Fibrosis volume. (C
red dashed lines indicate SD.index. The categorical variables are presented as a
frequency or percentage and were compared by us-
ing the Fisher exact test. A multiple regression was
used to analyze the predictive independence of fat
deposition and ﬁbrosis volumes on global cardiac
functional variables. For each test applied in thisme for Interobserver Variability
) Fat volume. Green dashed line indicates the mean difference and
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893study, p values #0.05 were considered to indicate
signiﬁcance. All statistical analyses were performed
using SPSS software (version 13.0, SPSS, Chicago,
Illinois) and GraphPad Prism statistical software
(GraphPad Software version 5.01, San Diego,
California).
RESULTS
Patient population. Sixteen patients were excluded,
including 3 due to claustrophobia, 4 due to refusing
to undergo CMR imaging, and the rest due to poor
image quality as a result of inability to repeatedly
suspend respiration for periods of 15 to 20 s. Finally,
124 patients were enrolled in this study. Table 1
summarizes the clinical characteristics in the study
population.
Reproducibility. The interobserver means of LGE,
fat, and ﬁbrosis were 18.39  9.0 ml, 9.18  5.42
ml, and 9.75  6.34 ml, respectively. The corre-
sponding difference between the means of LGE,
fat, and ﬁbrosis were 0.07  0.69 ml, 0.07  0.34
ml, and 0.16  0.35 ml, respectively. This is pre-
sented graphically for interobserver variability forFigure 2. Fat Deposition in a 32-Year-Old Man With DCM
Contrast-enhanced (A) fat, (B) water, and (D) corresponding fat fraction
imaging shows intramural enhancement adjacent to the right ventricula
DCM ¼ dilated cardiomyopathy; other abbreviation as in Figure 1.LGE (Fig. 1A), ﬁbrosis (Fig. 1B), and fat (Fig. 1C).
Results from the Bland and Altman analyses for
interobserver variability are presented as mean and
the difference between the 95% conﬁdence limits of
the bias.
Fat and ﬁbrosis deposition analysis. Patients in this
DCM cohort had a 41.9% (52 of 124) prevalence of
positive LGE, including a 12.9% (16 of 124)
prevalence of fat deposition. The patients were
divided into 3 groups as follows: those with negative
LGE, those with LGE but no fat deposition, and
those with LGE and fat deposition. There were no
patients demonstrating fat deposition without
ﬁbrosis. Examples of patients with fat deposition are
shown in Figures 2, 3, and 4. Higher volumes of
LGE were found in the group with myocardial fat
deposition (18.39  9.0 cm3 vs. 13.40  6.54 cm3;
p ¼ 0.001), as well as a higher ratio of LGE/LVM
(13.60  4.58% vs. 19.11  7.78%; p ¼ 0.000).
Of 16 patients with fat deposition, 13 (81.3%)
had fat deposition at the septum (Figs. 2, 4, and 5),
2 (12.5%) at the apex (Fig. 3), and the remaining
one (6.3%) at the inferior wall. In this group, fat
deposition occurred in distinct intramural patterns:map images show fat deposition in the intramural septum. (C) LGE
r subendocardium indicating that ﬁbrosis is combined with fat tissue.
Figure 3. Fat Deposition in a 44-Year-Old Woman With Palpitation and Shortness of Breath
Turbo spin echo (A) T1WI, (B) T2WI, (C) TIRM, (D) LGE, (E) water, and (F) fat images show fat deposition at left ventricular (LV) apex and
adjacent intramural septum suggesting left ventricular apical hypoplasia, with linear ﬁbrosis (D, arrow). Abbreviation as in Figure 1.
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894midwall striae or patches of intramural enhance-
ment. In the LGE without fat deposition subgroup,
25 of 36 patients (69.4%) had LGE at the septum,
5 (13.9%) at the apex, 4 (11.1%) at the septum and
adjacent inferior wall, and the remaining 2 (5.6%) at
the lateral wall. In the patterns of LGE, we found 2
distinct phenomena: subendocardial enhancement
including subendocardial extension toward the
epicardium (7 of 36 [19.4%]) and midwall striae or
patches of enhancement (29 of 36 [80.6%]).
There was no signiﬁcant difference between the
groups with and without LV fat deposition with
respect to body mass index and body surface area
(Table 1). Patients with fat deposition were younger
(vs. positive LGE without fat deposition) and had a
larger volume of LGE and a larger percentage of
LGE of LVM (Table 2). In the group with
myocardial fat deposition, the ﬁbrosis volume was
signiﬁcantly lower than that of the positive LGE
without fat deposition group (9.46  4.84 ml vs.
13.60  4.58 ml; p ¼ 0.000).
Global cardiac function. In this study, LVEF,
LVEDV, LVEDV index, LVESV, LVESV index,
CO, and cardiac index were signiﬁcantly different
among the 3 subgroups (negative LGE group,
positive LGE group, and fat deposition group)
(Table 2). In addition, there were signiﬁcant dif-
ferences in LVEF, LVEDV, LVEDV index,LVESV, and LVESV index in pairwise compari-
sons within the 3 groups. The mean LVEF in the
fatty deposition group was the lowest (21.1%),
compared with that in the positive LGE (30.0%)
and negative LGE groups (34.5%; p ¼ 0.000).
Logically, the LVEDV, LVEDV index, LVESV,
and LVESV index were the highest in the fat
deposition group, whereas those values were the
lowest in the negative LGE group. In addition, only
the CO and cardiac index were signiﬁcantly
different between the groups with fat deposition and
the negative LGE group; patients with fat deposi-
tion had signiﬁcantly decreased CO and cardiac
index compared with those in the negative LGE
group. LVM was not different among the 3 groups
(p ¼ 0.07).
Predictors of cardiac function. In the patientswith fat
deposition, there was a signiﬁcant positive correlation
between ﬁbrosis and fat volumes. There was a sig-
niﬁcant inverse correlation of fat volumes (p¼ 0.0008;
R2 ¼ 0.5624; slope 0.937) (Fig. 6) and ﬁbrosis
volumes (p ¼ 0.001; R2 ¼ 0.5308; slope 0.817)
(Fig. 7) with LVEF. However, there were no signif-
icant univariate correlations of fat volumes with
LVEDV index (p ¼ 0.874), LVESV index
(p ¼ 0.286), LVM index (p ¼ 0.153), and cardiac
index (p¼ 0.218). In addition, there was a univariate
correlation between fat and ﬁbrosis volumes (Fig. 8).
Figure 4. Fat Deposition in a 56-Year-Old Man With Chest Tightness and
Palpitation for 7 Years
(A and B) LGE and (C and D) fat images show severe midwall striae of enhancement
involving the septum and basal to mid-LV regions. Abbreviations as in Figures 1 and 4.
Figure 5. Explanted Heart of a 56-Year-Old Man
(A) The patient from Figure 4 at midseptal level shows the gross morphological features of
fat and ﬁber inﬁltration. (B) The yellow-white layer in the intramural septal myocardium
(black arrowheads, A) is composed of fat and ﬁber tissue in hematoxylin and eosin–
stained photomicrographs. The lesion is composed of fat cells (asterisks) and ﬁber bundles
(stars).
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895For the ﬁbrosis group, there were signiﬁcant univari-
ate correlations of ﬁbrosis volumes with LVEF
(p ¼ 0.001; R2 ¼ 0.78; slope 0.82) and LVM index
(p ¼ 0.005; R2 ¼ 0.44; slope 1.17).
Multiple regression with fat and ﬁbrosis volumes
as independent variables showed that fat volume
was an independent predictor of the global cardiac
functional parameter LVEF (p ¼ 0.003). The
regression equation is LVEF ¼ 42.18  (0.48 
fat)  (0.321  LVM)  (0.17  ﬁbrosis)
(p< 0.001). Fibrosis was signiﬁcantly correlated with
LVEF and LVM index in the myocardial fat depo-
sition group and the positive LGE group (p ¼ 0.009
and p ¼ 0.014, respectively) (Fig. 6).
D I SCUSS ION
In this prospective study, we noninvasively evaluated
myocardial fat deposition in patients with DCM by
using MR fat-water separation imaging combined
with LGE imaging. To our knowledge, this is the
ﬁrst research concerning the prevalence of fat
deposition in DCM. In addition, we investigated
the association among myocardial fat deposition,
ﬁbrosis, and quantitative global cardiac functional
variables.
We obtained several results from the present
study. First, fat deposition is a common phenome-
non in DCM. In this patient cohort, the prevalence
of fat deposition was 12.9%. Second, we found an
association between fat deposition and global car-
diac function (LVEF), as well as ﬁbrosis and LVM.
Although fat deposition, ﬁbrosis, and LVM index
were independent predictors for the global cardiac
functional parameter LVEF from the multiple
regression analysis, the cause and effect are un-
known at this stage but should be investigated in
multicenter studies with larger cohorts.
CMR LGE imaging has proven to be an accurate
technique for ﬁbrosis location and extension (23).
Factors such as fat suppression and choice of
opposed phased-echo times may alter the perceived
LGE size by using this technique. Fat deposition or
choice of imaging parameters may alter or even be
the source of the heterogeneous signal intensity
behavior in myocardial ﬁbrosis. The prevalence of
ﬁbrosis in DCM detected by LGE reported in the
literature was not very consistent, ranging from 31%
to 88% (6,24–26). In the population in this study, a
relatively higher prevalence of ﬁbrosis was observed.
One probable reason may be selected population
referral bias, which means that the results may not
be generalizable to the entire population. However,
we believe that the more likely reason if a truehigher prevalence of ﬁbrosis in the Chinese popu-
lation compared with that of European countries.
Interestingly, in this study, because fat deposition
was found in LV myocardium combined with
ﬁbrosis, we believe that ﬁbrosis is a precursor to
myocardial fat deposition in DCM. To verify this
hypothesis, a larger sample with long-term follow-up
should be investigated. We also found that fat
deposition was predominantly midmyocardial or
subepicardial, which was similar to the characteristics
of LGE inDCM(6,27). Aswe know,CMR imaging
may be the best noninvasive image modality for the
Table 2. Fibrosis and Fat Deposition Results
All Patients
(N [ 124)
Negative LGE
(n [ 72)
Fat Deposition Absent
(n [ 36)
Fat Deposition Present
(n [ 16) p Value
LVEF, % 31.5  8.9 34.5  6.04 30.0  10.7* 21.1  7.1*y 0.000
LV mass, g 98.4  19.6 102.2  14.49 92.6  24.5 94.1  24.6 0.072
LVEDV, ml 214.7  24.8 203.9  13.6 218.9  23.1* 253.7  27.0*y 0.000
LVEDV index, ml/m2 121.7  17.6 116.6  14.7 123.4  15.8* 140.8  20.2*y 0.000
LVESV, ml 148.9  35.6 134.2  20.9 155.2  36.8* 201.1  33.9*y 0.000
LVESV index, ml/m2 84.2  20.3 76.8  14.4 87.0  20.3* 111.3  19.2*y 0.000
CO, l/min 4.46  0.81 4.64  0.62 4.33  1.02 3.91  0.77* 0.030
Cardiac index, l/min/m2 2.54  0.57 2.66  0.48 2.46  0.70 2.18  0.50* 0.006
LGE volume, cm3 6.26  8.89 0.00 13.40  6.54 18.39  9.0* d
LGE/LV mass, % 6.41  8.57 0.00 13.60  4.58 19.11  7.78* d
Fibrosis volume, ml 5.16  7.47 0.00 13.44  6.62 9.75  6.34* d
Fibrosis of myocardial volume, % 5.36  7.37 0.00 13.72  4.61 10.02  5.17* d
Fat deposition volume, ml 1.24  3.79 0.00 0.00 9.57  5.69 d
Fat deposition of myocardial volume, % 1.36  4.28 0.00 0.00 10.52  6.88 d
Fat deposition of LGE volume, % 6.25  17.77 0.00 0.00 48.40  20.32 d
Ratio of fat to ﬁbrosis volume 0.21  0.91 0.00 0.00 1.64  2.05 d
Values are mean  SD. *Statistically signiﬁcant (p# 0.05) compared with the negative LGE group. yStatistically signiﬁcant (p # 0.05) compared with the fat deposition
absent group.
CO ¼ cardiac output; LV ¼ left ventricular; LVEDV ¼ left ventricular end-diastolic volume; LVEF ¼ left ventricular ejection fraction; LVESV ¼ left ventricular end-
systolic volume; other abbreviation as in Table 1.
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896detection of fat tissue in vivo owing to its sensitivity to
the off-resonance properties of fat and allowing fat-
water separation imaging combined with LGE
imaging for detection of ﬁbrosis. Both fat-water
separation and LGE imaging depict not only fat
and ﬁbrosis but also the entire myocardium. This
allowed identiﬁcation of the location within the LV
wall of both fat deposition and ﬁbrosis. Furthermore,
1 patient in the cohort had the pathological validation
for LV adipose tissue detected by CMR, and theFigure 6. Fat Deposition Volumes Are Univariate
Predictors of LVEF
LVEF ¼ left ventricular ejection fraction.CMR ﬁndings were highly correlated with the his-
tological specimens.
However, the cause and pathogenesis of fat
deposition in DCM are still unclear, but the
possible mechanism in ischemic cardiomyopathy
(myocardial infarction) is that adipocytes were
transformed from ﬁbrocytes at the site of the peri-
scar region, where it was believed that the blood
ﬂow was still present (28,29). Interestingly, in our
study, we found that fat deposition coincided withFigure 7. Fibrosis Volumes Are Univariate Predictors of LVEF
Abbreviation as in Figure 6.
Figure 8. Fat Deposition Volume Is a Signiﬁcant
Predictor of LV Mass
Abbreviation as in Figure 3.
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897the presence of ﬁbrotic tissue in the LV myocar-
dium. Therefore, the mechanism of fat deposition
in DCM may be the same occurring in myocardial
infarction.
Little is known about the prognostic signiﬁcance
or factors leading to myocardial fat deposition in
patients with DCM so far. The present study
implied that fat deposition is most likely an indi-
cator of a worse prognosis compared with no fat/
ﬁbrosis deposition in DCM. In view of this, fat
deposition could be considered a predictor used to
grade the severity of DCM, although the cause and
effect are still unknown.
Study limitations. The ﬁrst major limitation of this
study was that there was only 1 patient with the
pathological validation for LV adipose tissue detected
by CMR. Ideally, CMR ﬁndings would be correlated
to histological specimens, but such examinations are
extremely difﬁcult to perform in vivo in human hearts
as opposed to experimental animal models. The
population was relatively small, and there was a
wide variety of times of DCM diagnoses and treat-
ment in this study. Patients in this study mostly
had long-term symptoms and had severely impaired
cardiac function. The present study did not analyze
the relationship between fat deposition and
clinical manifestations. The precise quantiﬁcation of
scar volume or fat volume needs 3-dimensional
acquisition; in the current study, we did not have3-dimensional LGE and fat-water images. However,
due to the small spacing between scan layers, it should
have little impact on fat quantitative evaluation. The
measurements of LV contractile function could be
affected by the intraobserver and interobserver vari-
ability, although such variability is expected to be
small in magnitude owing to the high accuracy and
precision of CMR measurements (30). Fat-water
separation on the inversion recovery prepared multi-
echo imageswill introduce one extraT1weighting. In
the VARPRO ﬁtting scheme used in the study, the
T1 weighting effects were not considered. However,
the imaging sequences used were segmented, and a 2-
RR interval guarantees a good T1 recovery between
readouts, given that fat-water imaging is performed
after injection of contrast agents. Multiple compari-
sons were made in the same data set, and actual p
values are reported without adjustment for multiple
comparisons to the nominal signiﬁcance level of 0.05.
This allows the readers to focus on comparisons of
interest and make any multiple comparison adjust-
ments on their own. A larger study is needed to
conﬁrm that there are in fact 2 groups.CONCLUS IONS
A relatively high prevalence of myocardial fat
deposition was found in patients with DCM. Fat
deposition volume is signiﬁcantly related to LV
global function including LVEF, LVEDV index,
LVESV index, and LVM and may be a worse
predictor index for the prognosis of DCM.Acknowledgment
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